Copy protection

Tuesday, June 25, 2019

MEXICAN HEALTH AUTHRITY (COFEPRIS) GUIDELINE


MEXICAN HEALTH AUTHRITY (COFEPRIS) GUIDELINE

The Mexican halth authority guideline is not much popular in the pharmaceutical sector compaired to the other regulatory agencies guidelines. 

The Mexican heath authority which is called as COFEPRIS. The full form of the COFEPRIS is “Comisión Federal para la Protección contra Riesgos Sanitarios”.


COFEPRIS is an official organisation of the Mexican government. This agency is founded to monitor and control manufacturing and import of the health products. 

The health products include Medicinal finished dosage forms, active pharmaceutical ingredients, organ transplants etc.
The COFEPRIS authority has their own guideline to approve the drug product manufacturers and active drug manufacturers.  

The applicable COFEPRIS guideline are-

NOM 164 SSA1 2015: - This guideline is applicable for the active drug manufacturers like API, drug products in the form of semi-finished goods like pellets, DC powders.

NOM 159 SSA1 2016: - This guideline is applicable to the manufacturers of the finished products like tables, capsules, ointments, medicated creams etc.

These both guidelines are having very minor difference in the contents. The COFEPRIS guidelines are much more focused on the risk assessment on all the quality management functions.

The contents of the Mexican health authority guideline (NOM 164 SSA1 2015) are descried below-

0. Introduction.
1. Objective and field of application.
2. References.
3. Definitions.
4. Symbols and abbreviations.
5. Quality Management System
6. Quality Risk Management.
7. Personnel
8. Facilities and equipment.
9. Qualification and Validation.
10. Production systems.
11. Quality Control Laboratory.
12. Product Recall
13. Outsourced Activities
14. Destruction and final disposal of waste
15. Distributors
16. Manufacture of drug substances for use in clinical studies.
17. Compliance with international and Mexican standards.
18. Bibliography
19. Observance.
20. Validity. 20.1 Normative appendix A. Manufacturing areas classification.
20.2 Normative appendix B. Annual Product Review


The contents of the Mexican health authority guideline (NOM 159 SSA1 2016) are descried below-


1. Objective and application field.

2. References.

3. Definitions.

4. Symbols and abbreviations.

5. Quality Management System.

6. Quality Risks Management.

7. Personnel.

8. Facilities and equipment.

9. Qualification and validation.

10. Manufacturing systems.

11. Quality Control Laboratory.

12. Finished product release.

13. Market Product Recall.

14. Subcontracted activities.

15. Wastes Final Destination.

16. Good Storage and Distributions Practices.
17. Agreement with international and Mexican standards.

18. Bibliography.

19. Compliance.
20. Validity
21. Appendixes.
21.1. Normative Appendix A. Manufacturing Areas Classification.
21.2. Normative Appendix B. Product Annual Checking.


No comments:

Post a Comment

Top 10 Pharmaceutical companies in India

The pharmaceutical sector is struggling now a days with the compliance, data integrity and raw material availability issues. The ...